What are the potential birth defects of famciclovir?

What birth defects have been reported with famciclovir in animal studies?

Animal reproduction studies showed that famciclovir caused reduced fetal weight, delayed bone formation, and skeletal malformations in rats and rabbits at doses several times higher than those used in humans.

Do human studies show the same risks?

No controlled human data exist. Available pregnancy registries and post-marketing reports have not identified a clear pattern of birth defects linked to famciclovir, but the number of exposures remains too small to rule out risk.

Can famciclovir be used during pregnancy?

Current guidelines recommend reserving famciclovir for cases where the benefit outweighs potential risk, typically when safer alternatives such as acyclovir are not appropriate. Women who become pregnant while taking the drug are advised to enroll in a pregnancy registry.

How does famciclovir compare with acyclovir in pregnancy?

Acyclovir has a larger body of human safety data and is generally preferred. Famciclovir is converted to penciclovir, which has shown embryo-fetal toxicity in animals at lower relative doses than acyclovir, leading clinicians to favor acyclovir when antiviral treatment is needed.

When does the famciclovir patent expire and what does that mean for generic access?

The key U.S. patents listed on DrugPatentWatch.com expired in 2010, allowing multiple generic versions to enter the market and reducing cost for patients who require long-term suppression therapy.

[1] https://www.drugs.com/pregnancy/famciclovir.html
[2] https://www.drugpatentwatch.com/drug/famciclovir